Zions Bancorporation’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $222K | Buy |
4,944
+732
| +17% | +$41.1K | 0.01% | 311 |
|
|
2024
Q3 | $265K | Buy |
4,212
+138
| +3% | +$8.05K | 0.02% | 304 |
|
|
2024
Q2 | $241K | Buy |
4,074
+2,388
| +142% | +$149K | 0.02% | 307 |
|
|
2024
Q1 | $134K | Buy |
1,686
+947
| +128% | +$72.3K | 0.01% | 344 |
|
|
2023
Q4 | $58.4K | Buy |
739
+168
| +29% | +$12K | ﹤0.01% | 402 |
|
|
2023
Q3 | $39.9K | Sell |
571
-10
| -2% | -$709 | ﹤0.01% | 416 |
|
|
2023
Q2 | $40.2K | Sell |
581
-40
| -6% | -$2.85K | ﹤0.01% | 418 |
|
|
2023
Q1 | $46.1K | Sell |
621
-251
| -29% | -$21K | ﹤0.01% | 429 |
|
|
2022
Q4 | $81.3K | Sell |
872
-238
| -21% | -$23K | 0.01% | 383 |
|
|
2022
Q3 | $106K | Sell |
1,110
-1,340
| -55% | -$133K | 0.01% | 344 |
|
|
2022
Q2 | $227K | Sell |
2,450
-122
| -5% | -$11.9K | 0.02% | 301 |
|
|
2022
Q1 | $260K | Buy |
2,572
+1,386
| +117% | +$146K | 0.02% | 299 |
|
|
2021
Q4 | $122K | Buy |
1,186
+167
| +16% | +$15.4K | 0.01% | 355 |
|
|
2021
Q3 | $87K | Sell |
1,019
-46
| -4% | -$3.85K | 0.01% | 388 |
|
|
2021
Q2 | $89K | Sell |
1,065
-1,226
| -54% | -$100K | 0.01% | 364 |
|
|
2021
Q1 | $172K | Sell |
2,291
-294
| -11% | -$21.4K | 0.02% | 292 |
|
|
2020
Q4 | $177K | Sell |
2,585
-229
| -8% | -$14.9K | 0.02% | 273 |
|
|
2020
Q3 | $164K | Buy |
2,814
+1,178
| +72% | +$73.3K | 0.02% | 248 |
|
|
2020
Q2 | $107K | Sell |
1,636
-222
| -12% | -$14K | 0.02% | 269 |
|
|
2020
Q1 | $110K | Sell |
1,858
-522
| -22% | -$34.8K | 0.02% | 256 |
|
|
2019
Q4 | $176K | Buy |
2,380
+163
| +7% | +$11.4K | 0.03% | 248 |
|
|
2019
Q3 | $140K | Buy |
2,217
+82
| +4% | +$4.86K | 0.02% | 295 |
|
|
2019
Q2 | $116K | Sell |
2,135
-457
| -18% | -$24.6K | 0.02% | 289 |
|
|
2019
Q1 | $140K | Buy |
+2,592
| New | +$160K | 0.02% | 267 |
|
|
2018
Q4 | – | Sell |
-3,028
| Closed | -$239K | – | 569 |
|
|
2018
Q3 | $239K | Buy |
+3,028
| New | +$216K | 0.06% | 153 |
|
|
2018
Q2 | – | Sell |
-2,917
| Closed | -$182K | – | 500 |
|
|
2018
Q1 | $182K | Buy |
+2,917
| New | +$209K | 0.04% | 144 |
|
|
2017
Q4 | – | Sell |
-5,782
| Closed | -$469K | – | 699 |
|
|
2017
Q3 | $469K | Sell |
5,782
-3,169
| -35% | -$251K | 0.07% | 158 |
|
|
2017
Q2 | $720K | Sell |
8,951
-1,881
| -17% | -$149K | 0.12% | 90 |
|
|
2017
Q1 | $852K | Sell |
10,832
-4,387
| -29% | -$350K | 0.16% | 65 |
|
|
2016
Q4 | $1.2M | Sell |
15,219
-756
| -5% | -$61.2K | 0.21% | 66 |
|
|
2016
Q3 | $1.41M | Buy |
15,975
+534
| +3% | +$50.4K | 0.27% | 53 |
|
|
2016
Q2 | $1.49M | Buy |
15,441
+233
| +2% | +$23.2K | 0.26% | 53 |
|
|
2016
Q1 | $1.54M | Buy |
15,208
+400
| +3% | +$38.9K | 0.28% | 52 |
|
|
2015
Q4 | $1.38M | Buy |
14,808
+13,325
| +899% | +$1.31M | 0.24% | 56 |
|
|
2015
Q3 | $146K | Buy |
1,483
+1,432
| +2,808% | +$151K | 0.03% | 116 |
|
|
2015
Q2 | $5K | Sell |
51
-1,688
| -97% | -$172K | ﹤0.01% | 238 |
|
|
2015
Q1 | $179K | Buy |
+1,739
| New | +$176K | 0.03% | 133 |
|
Other funds holding CVS
Zions Bancorporation's CVS Position: Q4 2024 in Review
Zions Bancorporation increased its CVS Health (CVS) stake by 17% in Q4 2024, buying an estimated $41.1K and bringing the position to 4,944 shares worth $222K. The position accounts for 0.01% of the portfolio, ranked #311.
Zions Bancorporation first reported a position in CVS in Q1 2015 and has held it in 37 quarters since. The position peaked at $1.54M in Q1 2016. 1,669 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- Zions Bancorporation held 4,944 shares of CVS Health worth $222K as of Q4 2024.
- Zions Bancorporation bought 732 CVS Health shares in Q4 2024, an estimated $41.1K.
- CVS Health made up 0.01% of Zions Bancorporation's portfolio in Q4 2024, its #311 holding.
- Zions Bancorporation first reported a position in CVS Health in Q1 2015 and has held it in 37 quarters since.
- Zions Bancorporation's CVS Health position peaked at $1.54M in Q1 2016.
- 1,669 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.